Lite Strategy, Inc. (LITS)
Nasdaq: LITS · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2003
Who owns Lite Strategy, Inc.
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
6
report now, of 23 people on the record since 2008. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
Kenneth Griffin
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.00000002 per share (the "Shares") · reported falling below 5%, from 9.99% in Jul 29, 2025
Anson Funds Management LP
SCHEDULE 13D/A · filed Jul 24, 2025 · Common Stock, $0.00000002 par value · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Oct 31, 2025 · Common Stock · reported falling below 5%
Alexander Schornstein
SCHEDULE 13G/A · filed Aug 3, 2026 · Common Stock par value $0.00000002 · reported falling below 5%, from 9.99% in Dec 22, 2025
What LITS reports owning in othersstakes of 5% or more, and other ties
Lite Strategy, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
3purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Oct 26, 2025 to Oct 26, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 26, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 33 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Schornstein Alexander | 10% owner | 1 | $900,000 | 0 | 0 | $0 |
| Flynn James P | director | 0 | $0 | 0 | 3 | $100,000 |